pocketful logo light
pocketful logo light
Neuland Laboratories Ltd logo

Neuland Laboratories Ltd

NSE: NEULANDLAB BSE: 524558

₹19506

(0.18%)

Thu, 16 Jul 2026, 07:41 am

mtf coin illustrationMTF 5x

Neuland Laboratories Share Price Live Chart

1 Day

(0.18%)

No Result Found

Summary

  • Market Cap (in Cr)

    21897.93

  • Net Profit (in Cr)

    260.11

  • P/B

    10.22

  • Sector P/E

    33.76

  • P/E

    59.90

  • EV/EBITDA

    36.84

  • Debt/Equity (Industry)

    0.17

  • Interest Cover (Industry)

    18.17

  • ROCE (Industry)

    20.59

  • RONW (Industry)

    17.62

  • ROE

    14.84

  • ROCE

    18.58

  • Debt/Equity

    0.09

  • EPS (TTM)

    283.71

  • Dividend Yield

    0.20

  • Book Value

    1460.31

  • Interest Cover

    34.40

Analysis

No Result Found

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters32.6332.6332.6432.6832.68
FII20.4620.9020.6021.6922.11
DII15.8414.7113.5411.5710.97
Public31.0731.7632.8133.6733.84
Government0.000.000.400.400.40

Read More

Technical Analysis

RSI

61.39

MACD

543.08

50 DMA

17581.80

200 DMA

15478.23

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic22666.3320292.3319435.6717918.3317061.6715544.3313170.33
Fibonacci20292.3319385.4718825.2017918.3317011.4716451.2015544.33
Camarilla19231.8519014.2318796.6217918.3318361.3818143.7717926.15

Pivots Level: Classic

R3

+4748

22666.33

R2

+2374

20292.33

R1

+1517.33

19435.67

17918.33
17918.33
Pivot Point
LTP: 18907

S1

-856.67

17061.67

S2

-2374

15544.33

S3

-4748

13170.33

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    18952.75

  • 20-EMA

    18572.87

  • 30-EMA

    18190.90

  • 50-EMA

    17510.65

  • 100-EMA

    16440.25

  • 200-EMA

    15465.65

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
12 May 2026agm
12 May 2026board-meetingsAccounts, Quarterly Results, Final Dividend
09 Feb 2026board-meetingsQuarterly Results
07 Nov 2025board-meetingsQuarterly Results
18 Jun 2025dividendFinal Dividend - Rs. - 1218 Jul 2025
15 May 2025dividend₹12.00 Dividend /Share18 Jul 2025
15 May 2025agm
12 Jun 2024dividendAnnual General Meeting/Dividend - Rs 14 Per Share13 Jul 2024
10 May 2024dividend₹14.00 Dividend /Share13 Jul 2024
10 May 2024agm

Read More

Peer Comparison

Neuland Laboratories Ltd logo

Neuland Laboratories Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Cipla Ltd logo

Cipla Ltd

Read More

Neuland Laboratories Ltd About

Neuland Laboratories is engaged in manufacturing and selling of bulk drugs and caters to both domestic and international markets.

Industry

Pharmaceuticals - Indian - Bulk Drugs

Founded

1984

Headquarters

CEO

D Saharsh Rao

Employees

Contact

Website icon

Website

http://www.neulandlabs.com

Email icon

Email

ir@neulandlabs.com

Phone icon

Phone

91-40-30211600

Location icon

Location

11 Th Floor Phoenix IVY Buildi, Plot No 573A-III Road No 82, Hyderabad, Telangana, 500035

Read More

Neuland Laboratories Ltd Company History

YearHistory
2012
  • Neuland Laboratories Ltd issued rights in the ratio of 5:12.
  • The registered office of the company was shifted to Sanali Info park, 'A' Block, Ground floor,8-2-120/113, Road No.2, Banajara Hills, Hyderabad- 500034.
2013
  • The board recommended a dividend of Rs. 1.20 per share of a face value of Rs. 10 each.
  • Neuland Labs received the 2013 CMO Leadership Award for Regulatory Excellence.
2014
  • Neuland Labs inaugurated a new manufacturing facility constructed for its collaboration with Mitsubishi Healthcare Unit API Corporation.
  • The board recommended a dividend of 30% at Rs. 3 per equity share on a face value of Rs. 10 each.
  • Neuland Laboratories announced rights in the ratio of 4:25.
2016
  • The company entered into a Joint Development Agreement with Phoenix Embassy Techno Zone Private Limited.
2017
  • Neuland Labs completed the acquisition of an API plant.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
AIRAVAT CAPITAL TRUST IIblockBuy88961461205 Sept 2025
AIRAVAT CAPITAL TRUSTblockSell88961461205 Sept 2025
SMALLCAP WORLD FUND INCbulkSell48443415618.1612 Dec 2024
MALABAR INDIA FUND LIMITEDblockSell130000740026 Jun 2024
SMALLCAP WORLD FUND INCblockBuy130000740026 Jun 2024
SMALLCAP WORLD FUND INCbulkBuy130000740026 Jun 2024
MALABAR INDIA FUND LIMITEDbulkSell130000740026 Jun 2024
RAMAMOHAN RAO DAVULURIbulkSell4000005012.4508 Dec 2023
BNP PARIBAS ARBITRAGEbulkSell648933871.3131 Aug 2023
BNP PARIBAS ARBITRAGEbulkBuy708972898.3815 May 2023

Read More

Neuland Laboratories Ltd News

Neuland Labs files BRSR for FY26

Neuland Laboratories filed its Business Responsibility and Sustainability Report for FY 2025-26. Exports accounted for 76% of revenue.

09 Jul 2026

companies

Neuland Labs to declare ₹34 dividend at AGM

Neuland Laboratories Limited will hold its 42nd AGM on August 4, 2026, via video conferencing. The Board has recommended a final dividend of ₹34 per share for FY 2025-26.

09 Jul 2026

companies

Neuland Labs sets July 24 record date

Neuland Laboratories Limited fixed July 24, 2026 as the record date for the final dividend for FY26. The 42nd AGM is scheduled for August 4, 2026, via video conferencing.

16 Jun 2026

companies

Neuland Labs to meet Goldman Sachs

Neuland Laboratories management will hold a non-deal roadshow with Goldman Sachs on June 11, 2026, in Hyderabad.

05 Jun 2026

companies

Neuland Labs to attend Nuvama UK Conference

Neuland Laboratories management will attend the Nuvama India Conference 2026 (UK Edition) in London on June 8 and 9, 2026, for group and one-on-one meetings.

03 Jun 2026

companies

Read More

Open Your Free Demat Account

Enter your phone number